Innovator scan
Leadingplayers profiled
Profile the players
We identified and profiled innovators developing VLP-based vaccines focused on infectious diseases.
Case Study · Technology Landscape
Weighing the promise of VLP vaccines.
A global vaccine developer wanted a clear picture of virus-like particle vaccines for infectious diseases. We profiled innovators, reviewed the science behind each platform and tested our findings with experts.
The Client
The client is a global healthcare company that develops vaccines and related medicines. It wanted to understand current and future trends, competing technologies and the challenges the field still faces.
The Challenge
Promising platform.
Know the hurdles.
Prescouter was asked to deep dive into virus-like particle vaccines targeting infectious diseases, covering current and future trends, available technologies, unmet needs and the stakeholders developing them.
-
Players
Innovators and leaders
Who is developing VLP vaccines.
-
Science
Platform biology
How each technology works.
-
Gaps
Unmet needs
Challenges still facing the field.
Our Approach
Pairing company claims with the science.
Literature review
Scienceclaims checked against data
Check the biology
We reviewed company claims and scientific literature to understand the biology behind each technology.
Expert interviews
Expertshypotheses tested
Test the hypotheses
Experts confirmed secondary findings and covered questions public sources could not answer.
The Outcome
A clear picture of where VLPs stand.
Prescouter presented the leading players and innovators in VLP vaccines, with the scientific and manufacturing pros and cons of each technology. The client gained a clear view of each platform’s development stage and the major unmet needs facing the industry.
-
Players
Leading innovators
Mapped across the VLP space.
-
Tradeoffs
Pros and cons
Scientific and manufacturing.
-
Gaps
Unmet needs
The challenges still to solve.
Platform claims are easy to make and hard to verify. Reading the biology alongside the pitch shows which technologies can really scale.
Let’s Talk
Which vaccine platforms deserve your bet?
Profile the innovators, check the science and find the gaps worth closing. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]